噻替派治疗中枢神经系统肿瘤的II期评估。
Phase II evaluation of thioTEPA for treatment of central nervous system tumors.
作者信息
Edwards M S, Levin V A, Seager M L, Pischer T L, Wilson C B
出版信息
Cancer Treat Rep. 1979 Aug;63(8):1419-21.
PMID:225030
Abstract
Nineteen patients with primary malignant gliomas were treated with thioTEPA. It was found to be ineffective in 13 evaluable patients.
摘要
19例原发性恶性胶质瘤患者接受了噻替派治疗。结果发现，在13例可评估的患者中，该治疗无效。
Zotero 插件